Alvotech (ALVO) vs BioCryst Pharmaceuticals, Inc. (BCRX)
A side-by-side comparison of Alvotech and BioCryst Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALVO
Alvotech
$6.08HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
BCRX
BioCryst Pharmaceuticals, Inc.
$8.12HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — ALVO vs BCRX
growth of $100 · dividends reinvested · last 4yALVO -45.4% (-14.0%/yr)BCRX -13.4% (-3.5%/yr)BCRX compounded faster over this window
ALVO BCRX
ALVO vs BCRX: by the numbers
- •BCRX is the larger company ($2.06B vs $2.06B market cap).
- •Both run net losses; ALVO's is the smaller (-36.51% vs -40.90% net margin).
- •ALVO grew revenue faster over the past five years (69.03% vs 64.07% CAGR).
Metrics side by side
Valuation
| Metric | ALVO | BCRX |
|---|---|---|
| P/S ratio | 4.18 | 2.19 |
| EV / EBITDA | 41.72 | N/A |
| FCF yield | N/A | 17.31% |
Profitability
| Metric | ALVO | BCRX |
|---|---|---|
| Gross margin | 60.45% | 97.82% |
| Operating margin | 9.62% | 38.98% |
| Net margin | -36.51% | -40.90% |
| ROIC | 3.61% | -89.73% |
Growth (annualized)
| Metric | ALVO | BCRX |
|---|---|---|
| Revenue CAGR (5Y) | 69.03% | 64.07% |
| Total return CAGR (5Y) | N/A | -10.02% |
Frequently asked
- Which has grown faster, ALVO or BCRX?
- Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus BCRX at 64.07%.
Go deeper
Dig into the metrics
Alvotech ROEBioCryst Pharmaceuticals ROEAlvotech operating marginBioCryst Pharmaceuticals operating marginAlvotech revenue growthBioCryst Pharmaceuticals revenue growthAlvotech free cash flowBioCryst Pharmaceuticals free cash flow
Alvotech & BioCryst Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.